GEN Exclusives

More »

GEN News Highlights

More »
May 8, 2013

CollabRx, GeneInsight to Co-Market Informatics Solution

  • CollabRx and GeneInsight will together deliver an informatics solution to support interpretation and reporting of genetic variants from sequencing-based tests, the firms today announced.

    The companies said their joint initiative is meant to support sequencing, interpretation, and reporting in the clinical laboratory. Under the terms of the agreement, CollabRx medical and scientific content will be made accessible through the GeneInsight knowledge management platform. Together, the firms will make this offering available to the clinical lab market. Financial terms of the agreement were not disclosed.

    "We are excited to work with GeneInsight to provide a key medical informatics capability to the genetic testing laboratory market to accelerate adoption of next-generation sequencing-based tests for cancer and beyond," Thomas Mika, CollabRx CEO, said in a statement.

Add a comment

  • You must be signed in to perform this action.
    Click here to Login or Register for free.
    You will be taken back to your selected item after Login/Registration.

Related content


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Patient Access to Genetic Information

Do you think patients have the absolute right to gain access to their own genetic information from medical or clinical laboratories?

More »